Preview

Epilepsy and paroxysmal conditions

Advanced search

РЕЗОЛЮЦИЯ СОВЕТА ЭКСПЕРТОВ О ПРИМЕНЕНИИ ТОПАМАКСА В ЛЕЧЕНИИ ЭПИЛЕПСИИ

About the Author

Редакционная Статья

Russian Federation


References

1. Kwan P, Sills GJ, Brodie MJ The mechanisms of action of commonly used antiepileptic drugs // Pharmacology & Therapeutics 90 (2001) 21– 34

2. Faught E. Topiramate in the treatment of partial and generalized epilepsy Neuropsychiatric Disease and Treatment 2007:3(6) 811–821

3. K.A. Lyseng-Williamson and L.P. Yang, Topiramate: a review of its use in the treatment of epilepsy, Drugs 67 (2007), pp. 2231–2256

4. Panayotopoulos A. Principles of Therapy in the Epilepsies / In: Panayotopoulos. A Clinical Guide to Epileptic Syndromes and their Treatment. — Springer, 2007. — P. 155–184.

5. Perucca E. A pharmacological and clinical review on topiramate, a new antiepileptic drug. Pharmacological Research, Vol. 35, No. 4, 1997

6. Privitera MD, Brodie MJ, Mattson RH, et al. Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy. Acta Neurol Scand 2003 Mar; 39 (3): Mar; 107 (3): 165-75

7. Marson AG, Al-Kharusi AM, Alwaidh M, et al. The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet 2007 Mar 24; 369 (9566): 1016-26

8. Marson AG, Al-Kharusi AM, Alwaidh M, et al. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet 2007 Mar 24; 369 (9566): 1000-15

9. К.Ю. Мухин, М.Д. Тысячина, Л.Н. Мухина, А.С. Петрухин Сравнительная эффективность и переносимость топирамата, вальпроатов и карбамазепина в монотерапии эпилепсии у детей и молодых взрослых // Рус журн дет невр. – 2008. – Т.III. – Вып. 2. – С. 3-48.

10. Arroyo S, Dodson WE, Privitera MD, et al. Randomized dose- controlled study of topiramate as first-line therapy in epilepsy. Acta Neurol Scand 2005 Oct; 112 (4): 214-22

11. Guerrini R, Carpay J, Groselj J, et al. Topiramate monotherapy as broadspectrum antiepileptic drug in a naturalistic clinical setting. Seizure 2005 Sep; 14 (6): 371-80

12. Glauser TA, Levisohn PM, Ritter F, et al. Topiramate in Lennox- Gastaut syndrome: open-label treatment of patients completing a randomized controlled trial. Epilepsia 2000; 41 Suppl. 1: S86-90

13. Wheless WJ, Neto W, Wang S; EPMN-105 Study Group. Topiramate, carbamazepine, and valproate monotherapy: double-blind comparison in children with newly diagnosed epilepsy // J Child Neurol. 2004 Feb;19(2):135-41

14. Levisohn PM, Holland KD. Topiramate or valproate in patients with juvenile myoclonic epilepsy: a randomized open-label comparison // Epilepsy Behav. 2007 Jun;10(4):547-52.

15. Coppola G. Treatment of partial seizures in childhood: an overview// CNS Drugs. 2004;18(3):133-56

16. Mikkonen K., Va niopaa K., Pakarinen A.J. et al. Long-term reproducyive endocrine health in yong women with epilepsy during puberty // Neurology. — 2004. — V. 62. — P. 445-50.

17. Morrell M.J., Montouris G.D. Reproductive disturbances in patients with epilepsy // Cleveland Clinic J Med. — 2004. — V. 71

18. (Suppl. 2). — P. 19-24

19. Pack A. M., Gidal B., Vazquez B. Bone disease associated with antiepilaptic drugs // Cleveland clinic journal of medicine. – 2004. – V. 71. – (Suppl 2) – P. 42-49

20. Penovich P.E., Eck K.E., Economou V.V. Recommendation for care of women with epilepsy // Cleveland Clin J Med. — 2004. — V. 71 (Suppl. 2). — P. 49-58.

21. Воронкова К.В. и соавт. Рациональная антиэпилептическая фармакотерапия. – М.: Бином пресс, 2008. – 192 с.

22. Goldensohn E.S., Glaser G.H., Goldberg M.A. Epilepsy //In: Merrits textbook of neurology/ Eds L.P.Rowland. – Lea@Febiger,

23. – 798 p.

24. Gros elj J., Guerrini R., Van Oene J., Lahaye M., Schreiner A., Schwalen S. Experience with topiramate monotherapy in elderly patients with recent onset epilepsy // Acta Neurol Scand 2005: 112: 144–150.

25. Ben-Menachem E. et al. Predictors of weight loss in adults with topiramate treated epilepsy // Obes Res. – 2003. – V. 11. – P. 556-62.

26. Bergey GK. Initial treatment of epilepsy: special issues in treating the elderly.// Neurology. 2004 Nov 23;63(10 Suppl 4):S40-8.

27. Bourgeois BF. Drug interaction profile of topiramate.// Epilepsia. 1996;37 Suppl 2:S14-S17.26. Panayotopoulos A. Principles of Therapy in the Epilepsies / In: Panayotopoulos. A

28. Clinical Guide to Epileptic Syndromes and their Treatment. — Springer, 2007. — P. 155–184.

29. Glauser T., Ben-Menachem E., Bourgeois B., Cnaan A., Chadwick D., Guerreiro C., et al. ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial .monotherapy for epileptic seizures and syndromes // Epilepsia. — 2006. — V. 47. — P. 1094– 120.

30. Epilepsy NICE guideline October 2004

31. FDA Approved Labeling Text dated 6/29/05; Package Insert – TOPAMAX®, HIGHLIGHTS OF PRESCRIBING INFORMATION, Revised December 2009, http://www.accessdata.fda.gov

32. AAN Guideline Summary for clinicians efficacy and tolerability of the new antiepileptic drugs, 1: the new antiepileptic drugs,1: treatment of the new onset epilepsy. NEUROLOGY 2004, 62:1252-60

33. К.Ю.Мухин, А.С.Петрухин, М.Б.Миронов. Клиническая эффективность и переносимость Топамакса при комбинированной терапии эпилепсии.// Журнал Неврологии и Психиатрии им. С.С.Корсакова, 2003;103(3):28-33.

34. Глухова Л.Ю., Мухин К.Ю., Петрухин А.С., Миронов М.Б. Топамакс в лечении симптоматической лобной эпилепсии.// Журнал Неврологии и Психиатрии им. С.С.Корсакова, 2003;103(12):51-2.

35. К.Ю. Мухин, Л.Ю. Глухова, А.С. Петрухин, М.Б. Миронов, А.М. Соборнова. Топамакс при монотерапии эпилепсии// Журнал Неврологии и Психиатрии им. С.С.Корсакова, 2004;104: 8: 35-40

36. K.Yu.Mukhin, A.S.Petrukin, M.B.Mironov. Topiramate as an add-on therapy in symptomatic partial epilepsies in children// Poster P 108// Psychiatric aspect of the epilepsies. Issues of comorbidity in

37. pediatric epilepsy// Bielefeld, Germany, May 29th – June 1st, 2003

38. Мухин К.Ю., Миронов М.Б., Тысячина М.Д., Алиханов А.А., Петрухин А.С. Электро-клиническая характеристика больных симптоматической фокальной эпилепсией с феноменом вторичной билатеральной синхронизации на ЭЭГ.// Русский журнал детской неврологии, 2006, том 1 выпуск 1, стр.6-17

39. Мухин К.Ю., Миронов М.Б., Тысячина М.Д., Петрухин А.С. Применение Топамакса в монотерапии у детей. Русский журнал детской неврологии, 2006, том 1 выпуск 2, стр.3-9

40. Мухин К.Ю., Петрухин А.С., Миронов М.Б. Клинический случай применения Топамакса в лечении юношеской миоклонической эпилепсии с фотосенситивностью. Вестник эпилептологии. 2006. №1 (05), 17-21.


Review

For citations:


  . Epilepsy and paroxysmal conditions. 2011;3(2):6-8. (In Russ.)

Views: 454


ISSN 2077-8333 (Print)
ISSN 2311-4088 (Online)